nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketotifen—PGD—Methotrexate—lymphatic system cancer	0.817	1	CbGbCtD
Ketotifen—Sleep disorder—Fludarabine—lymphatic system cancer	0.00478	0.0261	CcSEcCtD
Ketotifen—Erythema multiforme—Mechlorethamine—lymphatic system cancer	0.00417	0.0228	CcSEcCtD
Ketotifen—Cystitis noninfective—Bleomycin—lymphatic system cancer	0.00408	0.0223	CcSEcCtD
Ketotifen—Cystitis—Bleomycin—lymphatic system cancer	0.00403	0.022	CcSEcCtD
Ketotifen—Bladder pain—Bleomycin—lymphatic system cancer	0.00378	0.0206	CcSEcCtD
Ketotifen—Hepatic enzyme increased—Mitoxantrone—lymphatic system cancer	0.00358	0.0196	CcSEcCtD
Ketotifen—Stevens-Johnson syndrome—Fludarabine—lymphatic system cancer	0.00316	0.0172	CcSEcCtD
Ketotifen—Infection—Mechlorethamine—lymphatic system cancer	0.00312	0.017	CcSEcCtD
Ketotifen—Thrombocytopenia—Mechlorethamine—lymphatic system cancer	0.00307	0.0168	CcSEcCtD
Ketotifen—Epistaxis—Fludarabine—lymphatic system cancer	0.00301	0.0164	CcSEcCtD
Ketotifen—Erythema multiforme—Fludarabine—lymphatic system cancer	0.0027	0.0148	CcSEcCtD
Ketotifen—Hypertension—Teniposide—lymphatic system cancer	0.00245	0.0134	CcSEcCtD
Ketotifen—Infection—Teniposide—lymphatic system cancer	0.0023	0.0125	CcSEcCtD
Ketotifen—Thrombocytopenia—Teniposide—lymphatic system cancer	0.00226	0.0124	CcSEcCtD
Ketotifen—Pruritus—Mechlorethamine—lymphatic system cancer	0.00222	0.0121	CcSEcCtD
Ketotifen—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00215	0.0117	CcSEcCtD
Ketotifen—Infection—Fludarabine—lymphatic system cancer	0.00202	0.011	CcSEcCtD
Ketotifen—Vomiting—Mechlorethamine—lymphatic system cancer	0.00199	0.0109	CcSEcCtD
Ketotifen—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.00199	0.0109	CcSEcCtD
Ketotifen—Rash—Mechlorethamine—lymphatic system cancer	0.00198	0.0108	CcSEcCtD
Ketotifen—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00198	0.0108	CcSEcCtD
Ketotifen—Weight increased—Mitoxantrone—lymphatic system cancer	0.00193	0.0106	CcSEcCtD
Ketotifen—Drowsiness—Mitoxantrone—lymphatic system cancer	0.0019	0.0104	CcSEcCtD
Ketotifen—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00189	0.0103	CcSEcCtD
Ketotifen—Nausea—Mechlorethamine—lymphatic system cancer	0.00186	0.0102	CcSEcCtD
Ketotifen—Urticaria—Teniposide—lymphatic system cancer	0.00184	0.01	CcSEcCtD
Ketotifen—Abdominal pain—Teniposide—lymphatic system cancer	0.00183	0.00998	CcSEcCtD
Ketotifen—Body temperature increased—Teniposide—lymphatic system cancer	0.00183	0.00998	CcSEcCtD
Ketotifen—Paraesthesia—Fludarabine—lymphatic system cancer	0.00182	0.00996	CcSEcCtD
Ketotifen—Hepatic enzyme increased—Methotrexate—lymphatic system cancer	0.00179	0.00975	CcSEcCtD
Ketotifen—Pain—Fludarabine—lymphatic system cancer	0.00174	0.00949	CcSEcCtD
Ketotifen—Hepatitis—Mitoxantrone—lymphatic system cancer	0.0017	0.00929	CcSEcCtD
Ketotifen—Cystitis noninfective—Methotrexate—lymphatic system cancer	0.00165	0.00901	CcSEcCtD
Ketotifen—Pruritus—Teniposide—lymphatic system cancer	0.00164	0.00893	CcSEcCtD
Ketotifen—Cystitis—Methotrexate—lymphatic system cancer	0.00163	0.0089	CcSEcCtD
Ketotifen—Body temperature increased—Fludarabine—lymphatic system cancer	0.00161	0.00877	CcSEcCtD
Ketotifen—Diarrhoea—Teniposide—lymphatic system cancer	0.00158	0.00864	CcSEcCtD
Ketotifen—Bladder pain—Methotrexate—lymphatic system cancer	0.00153	0.00834	CcSEcCtD
Ketotifen—Infection—Bleomycin—lymphatic system cancer	0.00148	0.00808	CcSEcCtD
Ketotifen—Vomiting—Teniposide—lymphatic system cancer	0.00147	0.00803	CcSEcCtD
Ketotifen—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00146	0.00797	CcSEcCtD
Ketotifen—Rash—Teniposide—lymphatic system cancer	0.00146	0.00796	CcSEcCtD
Ketotifen—Dermatitis—Teniposide—lymphatic system cancer	0.00146	0.00795	CcSEcCtD
Ketotifen—Headache—Teniposide—lymphatic system cancer	0.00145	0.00791	CcSEcCtD
Ketotifen—Pruritus—Fludarabine—lymphatic system cancer	0.00144	0.00785	CcSEcCtD
Ketotifen—Diarrhoea—Fludarabine—lymphatic system cancer	0.00139	0.00759	CcSEcCtD
Ketotifen—Hypertension—Carmustine—lymphatic system cancer	0.00138	0.00751	CcSEcCtD
Ketotifen—Nausea—Teniposide—lymphatic system cancer	0.00137	0.0075	CcSEcCtD
Ketotifen—Paraesthesia—Bleomycin—lymphatic system cancer	0.00134	0.00731	CcSEcCtD
Ketotifen—Hypertension—Vincristine—lymphatic system cancer	0.00131	0.00717	CcSEcCtD
Ketotifen—Infection—Carmustine—lymphatic system cancer	0.00129	0.00706	CcSEcCtD
Ketotifen—Vomiting—Fludarabine—lymphatic system cancer	0.00129	0.00706	CcSEcCtD
Ketotifen—Rash—Fludarabine—lymphatic system cancer	0.00128	0.007	CcSEcCtD
Ketotifen—Dermatitis—Fludarabine—lymphatic system cancer	0.00128	0.00699	CcSEcCtD
Ketotifen—Hypertension—Mitoxantrone—lymphatic system cancer	0.00128	0.00698	CcSEcCtD
Ketotifen—Pain—Bleomycin—lymphatic system cancer	0.00127	0.00696	CcSEcCtD
Ketotifen—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00127	0.00695	CcSEcCtD
Ketotifen—Headache—Fludarabine—lymphatic system cancer	0.00127	0.00695	CcSEcCtD
Ketotifen—Infection—Vincristine—lymphatic system cancer	0.00123	0.00674	CcSEcCtD
Ketotifen—Thrombocytopenia—Vincristine—lymphatic system cancer	0.00122	0.00664	CcSEcCtD
Ketotifen—Nausea—Fludarabine—lymphatic system cancer	0.00121	0.00659	CcSEcCtD
Ketotifen—Infection—Mitoxantrone—lymphatic system cancer	0.0012	0.00656	CcSEcCtD
Ketotifen—Shock—Mitoxantrone—lymphatic system cancer	0.00119	0.0065	CcSEcCtD
Ketotifen—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00118	0.00646	CcSEcCtD
Ketotifen—Urticaria—Bleomycin—lymphatic system cancer	0.00118	0.00646	CcSEcCtD
Ketotifen—Body temperature increased—Bleomycin—lymphatic system cancer	0.00118	0.00643	CcSEcCtD
Ketotifen—Insomnia—Carmustine—lymphatic system cancer	0.00118	0.00642	CcSEcCtD
Ketotifen—Irritability—Methotrexate—lymphatic system cancer	0.00117	0.00639	CcSEcCtD
Ketotifen—Paraesthesia—Carmustine—lymphatic system cancer	0.00117	0.00638	CcSEcCtD
Ketotifen—Somnolence—Carmustine—lymphatic system cancer	0.00116	0.00631	CcSEcCtD
Ketotifen—Insomnia—Vincristine—lymphatic system cancer	0.00112	0.00613	CcSEcCtD
Ketotifen—Paraesthesia—Vincristine—lymphatic system cancer	0.00111	0.00609	CcSEcCtD
Ketotifen—Pain—Carmustine—lymphatic system cancer	0.00111	0.00607	CcSEcCtD
Ketotifen—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00109	0.00593	CcSEcCtD
Ketotifen—Somnolence—Mitoxantrone—lymphatic system cancer	0.00107	0.00587	CcSEcCtD
Ketotifen—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00106	0.00581	CcSEcCtD
Ketotifen—Pain—Vincristine—lymphatic system cancer	0.00106	0.0058	CcSEcCtD
Ketotifen—Pruritus—Bleomycin—lymphatic system cancer	0.00105	0.00576	CcSEcCtD
Ketotifen—Pain—Mitoxantrone—lymphatic system cancer	0.00103	0.00565	CcSEcCtD
Ketotifen—Body temperature increased—Carmustine—lymphatic system cancer	0.00103	0.00561	CcSEcCtD
Ketotifen—Abdominal pain—Carmustine—lymphatic system cancer	0.00103	0.00561	CcSEcCtD
Ketotifen—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00102	0.00554	CcSEcCtD
Ketotifen—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000989	0.0054	CcSEcCtD
Ketotifen—Abdominal pain—Vincristine—lymphatic system cancer	0.000981	0.00536	CcSEcCtD
Ketotifen—Body temperature increased—Vincristine—lymphatic system cancer	0.000981	0.00536	CcSEcCtD
Ketotifen—Urticaria—Mitoxantrone—lymphatic system cancer	0.000961	0.00525	CcSEcCtD
Ketotifen—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000956	0.00522	CcSEcCtD
Ketotifen—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000956	0.00522	CcSEcCtD
Ketotifen—Vomiting—Bleomycin—lymphatic system cancer	0.000947	0.00517	CcSEcCtD
Ketotifen—Drowsiness—Methotrexate—lymphatic system cancer	0.000945	0.00516	CcSEcCtD
Ketotifen—Rash—Bleomycin—lymphatic system cancer	0.000939	0.00513	CcSEcCtD
Ketotifen—Dermatitis—Bleomycin—lymphatic system cancer	0.000939	0.00513	CcSEcCtD
Ketotifen—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.000936	0.00511	CcSEcCtD
Ketotifen—Epistaxis—Methotrexate—lymphatic system cancer	0.000891	0.00486	CcSEcCtD
Ketotifen—Diarrhoea—Carmustine—lymphatic system cancer	0.00089	0.00486	CcSEcCtD
Ketotifen—Nausea—Bleomycin—lymphatic system cancer	0.000885	0.00483	CcSEcCtD
Ketotifen—Dizziness—Carmustine—lymphatic system cancer	0.00086	0.0047	CcSEcCtD
Ketotifen—Diarrhoea—Vincristine—lymphatic system cancer	0.000849	0.00464	CcSEcCtD
Ketotifen—Hepatitis—Methotrexate—lymphatic system cancer	0.000848	0.00463	CcSEcCtD
Ketotifen—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000827	0.00452	CcSEcCtD
Ketotifen—Vomiting—Carmustine—lymphatic system cancer	0.000827	0.00452	CcSEcCtD
Ketotifen—Dizziness—Vincristine—lymphatic system cancer	0.000821	0.00448	CcSEcCtD
Ketotifen—Rash—Carmustine—lymphatic system cancer	0.00082	0.00448	CcSEcCtD
Ketotifen—Dermatitis—Carmustine—lymphatic system cancer	0.000819	0.00447	CcSEcCtD
Ketotifen—Headache—Carmustine—lymphatic system cancer	0.000815	0.00445	CcSEcCtD
Ketotifen—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000802	0.00438	CcSEcCtD
Ketotifen—Vomiting—Vincristine—lymphatic system cancer	0.000789	0.00431	CcSEcCtD
Ketotifen—Rash—Vincristine—lymphatic system cancer	0.000783	0.00427	CcSEcCtD
Ketotifen—Dermatitis—Vincristine—lymphatic system cancer	0.000782	0.00427	CcSEcCtD
Ketotifen—Headache—Vincristine—lymphatic system cancer	0.000778	0.00425	CcSEcCtD
Ketotifen—Nausea—Carmustine—lymphatic system cancer	0.000773	0.00422	CcSEcCtD
Ketotifen—Vomiting—Mitoxantrone—lymphatic system cancer	0.000769	0.0042	CcSEcCtD
Ketotifen—Rash—Mitoxantrone—lymphatic system cancer	0.000762	0.00416	CcSEcCtD
Ketotifen—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000762	0.00416	CcSEcCtD
Ketotifen—Headache—Mitoxantrone—lymphatic system cancer	0.000757	0.00414	CcSEcCtD
Ketotifen—Nausea—Vincristine—lymphatic system cancer	0.000737	0.00403	CcSEcCtD
Ketotifen—Nausea—Mitoxantrone—lymphatic system cancer	0.000718	0.00392	CcSEcCtD
Ketotifen—Infection—Methotrexate—lymphatic system cancer	0.000598	0.00327	CcSEcCtD
Ketotifen—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.00059	0.00322	CcSEcCtD
Ketotifen—Insomnia—Methotrexate—lymphatic system cancer	0.000545	0.00298	CcSEcCtD
Ketotifen—Paraesthesia—Methotrexate—lymphatic system cancer	0.000541	0.00295	CcSEcCtD
Ketotifen—Somnolence—Methotrexate—lymphatic system cancer	0.000536	0.00292	CcSEcCtD
Ketotifen—Pain—Methotrexate—lymphatic system cancer	0.000515	0.00281	CcSEcCtD
Ketotifen—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000493	0.00269	CcSEcCtD
Ketotifen—Urticaria—Methotrexate—lymphatic system cancer	0.000479	0.00261	CcSEcCtD
Ketotifen—Body temperature increased—Methotrexate—lymphatic system cancer	0.000476	0.0026	CcSEcCtD
Ketotifen—Abdominal pain—Methotrexate—lymphatic system cancer	0.000476	0.0026	CcSEcCtD
Ketotifen—Pruritus—Methotrexate—lymphatic system cancer	0.000426	0.00233	CcSEcCtD
Ketotifen—Diarrhoea—Methotrexate—lymphatic system cancer	0.000412	0.00225	CcSEcCtD
Ketotifen—Dizziness—Methotrexate—lymphatic system cancer	0.000398	0.00218	CcSEcCtD
Ketotifen—Vomiting—Methotrexate—lymphatic system cancer	0.000383	0.00209	CcSEcCtD
Ketotifen—Rash—Methotrexate—lymphatic system cancer	0.00038	0.00207	CcSEcCtD
Ketotifen—Dermatitis—Methotrexate—lymphatic system cancer	0.000379	0.00207	CcSEcCtD
Ketotifen—Headache—Methotrexate—lymphatic system cancer	0.000377	0.00206	CcSEcCtD
Ketotifen—Nausea—Methotrexate—lymphatic system cancer	0.000358	0.00195	CcSEcCtD
